Innovations in cancers of the central nervous system
- Submission status
- Closed
- Submission deadline
This Collection aims to highlights the latest advances in research in brain cancers, with a focus on adult diffuse gliomas, glioblastomas, meningiomas and metastatic brain tumors. Tumors affecting the brain cause substantial morbidity and mortality and there is a significant need for improved detection, non-invasive monitoring strategies and more effective and durable treatments. The focus of the collection will be on recent advances in basic, translational and clinical research as well as offer expert commentary on strategies to move brain cancer diagnostics and therapeutics forward.
Topics of interest include:
- Advances in liquid biopsy for diagnosis and monitoring of nervous system cancers
- Preclinical disease models (patient-derived xenografts, organoids, genetically engineered models)
- Innovations in Immunotherapy
- Metabolic dysregulation in glioma
- Targeted therapies and resistance in brain tumors
- Cancer neuroscience and tumor-microenvironment
- Advances in imaging techniques
- Strategies for increasing CNS permeability of therapeutic agents
- Applications of Artificial Intelligence/Machine Learning to brain cancers
This Collection supports and amplifies research related to SDG 3.
Editors
-
Julie J. Miller
Massachusetts General Hospital, Harvard Medical School, USA.
-
Albert Kim
Massachusetts General Hospital, Harvard Medical School, USA.
Please follow the steps detailed on this page, to prepare your manuscript for submission. Submissions are handled via our online submission system. When filling out the manuscript information, in the "Subject Terms" tab, select the "Innovations in cancers of the central nervous system" Collection from the alphabetical list. Authors should express their interest in the Collection in their cover letter.
